ACM
MYOK

Atika Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Atika Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-56,000
Closed -$2.4M – 86
2017
Q3 		$2.4M Buy
+56,000
New +$1.79M 0.69% 56

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Atika Capital Management's MYOK Position: Q4 2017 in Review

Atika Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 56,000 shares — an estimated $2.4M sold.

Atika Capital Management first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $2.4M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • Atika Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Atika Capital Management sold 56,000 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $2.4M.
  • Atika Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Atika Capital Management's MyoKardia, Inc. Common Stock position peaked at $2.4M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Atika Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.